# Case Intake Frontier Completion Audit Handoff v0

Stewarded by [frg.earth](https://frg.earth/).

- disease program: `multiple-myeloma`
- artifact id: `multiple-myeloma-case-intake-frontier-completion-audit-handoff-v0`
- named frontier phase: `case-intake-frontier-v0`
- claim level: `open-question`
- status: `completion-audit-handoff-v0`
- last reviewed: `2026-04-16`
- clinical boundary: research-use-only phase handoff, not medical advice

## Purpose

This handoff records the public completion audit for the
`case-intake-frontier-v0` caregiver intake phase.

The phase now has a public-safe product spec, a fail-closed projection
checklist, and a synthetic fixture that covers the full intake flow without real
case data. This artifact closes the current public autonomous slice and marks
what remains blocked or requires a new named phase.

This is not an intake form, backend plan, live product, patient guide, diagnosis
tool, treatment recommender, trial matcher, prognosis tool, monitoring plan,
expanded-access guide, or cure claim.

## Completion Verdict

`case-intake-frontier-v0` is complete for the current public autonomous phase.

The public repo now has enough caregiver-intake foundation to let future work
inspect:

- what a caregiver-friendly intake flow should ask and refuse
- which fields are shape-only, unknown/not_sure capable, optional, or
  private-only
- what public projection gates block PHI, free text, uploads, advice, and
  publication
- how a synthetic fixture exercises the flow without resembling a real person
- which validators and review gates must remain in front of any future private
  intake or public learning

No real intake, upload flow, clinical interpretation, private-lab processing, or
publication action is authorized by this handoff.

## Evidence Map

| Phase requirement | Public evidence | Audit status |
| --- | --- | --- |
| Caregiver intake spec exists. | [Caregiver Case Intake Product Spec v0](caregiver-case-intake-product-spec-v0.md) defines the flow, field groups, private handoff boundary, unknown/not_sure behavior, final review, and no-advice copy seed. | pass |
| Public projection gate exists. | [Caregiver Intake Public Projection Checklist v0](caregiver-intake-public-projection-checklist-v0.md) defines fail-closed verdicts and blocks PHI, free text, uploads, advice, clinical interpretation, and publication bypass. | pass |
| Synthetic fixture covers the flow. | [Multiple Myeloma Synthetic Caregiver Intake v0](../../../examples/multiple-myeloma-synthetic-caregiver-intake-v0.json) includes `intake_00` through `intake_11`, including `intake_02_helper_context`, and carries a `synthetic-only-ok` projection verdict. | pass |
| No real case data appears. | The fixture is marked synthetic-only; it sets `uses_real_patient_data`, `contains_phi`, `contains_private_records`, and `contains_patient_specific_recommendation` to false. | pass |
| Unknown/not_sure states are preserved. | The product spec requires `known`, `unknown`, `not_sure`, and `not_collected`; the fixture includes unknown/not_sure values and `unknown_state_supported: true`. | pass |
| Final review and private handoff boundaries are preserved. | The product spec requires review before private handoff; the fixture keeps `final_review_required_before_private_handoff: true` and `public_submission_allowed: false`. | pass |
| Consent, privacy, clinician-review, and publication gates remain explicit. | The product spec, projection checklist, and fixture require consent/privacy review, clinician review, and publication gate before any future public learning. | pass |
| Case-to-cure linkage exists. | [Case-To-Cure Pipeline Blueprint v0](../case-to-cure-pipeline-blueprint-v0.md) links the intake spec and projection checklist as public method surfaces, not case records. | pass |
| Navigation and catalog coverage exist. | The disease README, case-intake README, public inventory, public artifact catalog, and machine-readable catalog link the case-intake phase artifacts. | pass |
| Validation remains required. | `make validate` passed for this handoff, checking 242 JSON files, and `make list-public-artifacts ARGS="--scope myeloma"` includes the handoff in the myeloma scope. | pass |

## Safety Boundary

The public case-intake phase cannot be used to:

- collect real case data
- store names, contact details, exact dates, notes, uploads, portal exports,
  reports, images, identifiers, or re-identification keys
- process signed consent records or private authorizations
- diagnose or stage multiple myeloma
- interpret disease state, response, MRD, relapse, labs, imaging, genomics,
  organ context, frailty, treatment history, or record completeness for a
  person
- recommend treatment, trials, monitoring, expanded access, urgency actions, or
  clinical next steps
- rank options, therapies, trials, products, clinicians, centers, sources,
  mechanisms, or evidence
- publish case-derived learning
- claim that multiple myeloma has been cured or that a vaccine has been found

## Remaining Blockers

These are not blockers to closing the public phase. They are blockers to any
downstream real-world use:

| Blocker | Why it remains blocked | Required gate |
| --- | --- | --- |
| Real caregiver intake | Would require real person data, consent, storage, access control, privacy review, and support process. | private-lab-needed |
| Live backend or upload flow | Would handle records, notes, images, portal exports, identifiers, or PHI. | private-lab-needed plus privacy/legal/security review |
| Clinical interpretation | Would convert source-stated fields into diagnosis, prognosis, treatment, trial, monitoring, urgency, or eligibility guidance. | clinical-team-needed |
| Public learning from a real case | Would require de-identification, aggregation, source review, clinician review, privacy review, and publication approval. | human-publication-gate-needed |
| Executable projection validator | Could be useful, but is not required for the current handoff and should be selected by a new named tooling phase. | new-named-phase-needed |
| Private-intake schema contract | Could be useful, but would define private data structure and should be selected by a new bounded schema or private-lab phase. | new-named-phase-needed |
| Static synthetic prototype | Could be useful, but should be selected by a new product/prototype phase with explicit no-real-data constraints. | new-named-phase-needed |

## Handoff State

The current public autonomous case-intake phase should stop here unless the ORP
live frontier points to a new named phase.

The next safe project-owned states are:

- protected-branch or maintainer review of the public case-intake phase
- a new named phase for an executable projection validator
- a new named phase for a private-intake schema contract
- a new named phase for a static synthetic prototype
- private-lab implementation outside this public repo, with consent, access
  controls, privacy review, clinician review, legal/regulatory review, and
  publication gates

## Review Boundary

This handoff organizes public research tooling. It does not provide medical
advice, diagnostic guidance, treatment guidance, trial guidance, eligibility
guidance, expanded-access guidance, monitoring guidance, urgency guidance, or a
claim that a cure or vaccine has been found.
